C

Centro Medico Teknon | Unidad de Medicina del Sueno

Research site

(Unclaimed)

Location

Calle Marquesa de Vilallonga, 12. Planta -1. Consulta 5, Barcelona, Barcelona, Spain

Site insights

Top conditions

Top treatments

Filgotinib

ABX464

Ara-C

Dexketoprofen Trometamol

PF-00547659

cyclophosphamide

melphalan

Tramadol Hydrochloride

Obefazimod

cytarabine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 25 total trials

ABTECT - Maintenance

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once d...

Enrolling

Ulcerative Colitis

Drug: ABX464

Drug: Placebo

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease (ENHANCE-CD)

This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase.The objective is to evaluate...

Enrolling

Moderately to Severely Active Crohn Disease

Drug: Obefazimod

Other: Placebo

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis (SELECTIONLTE)

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy...

Active, not recruiting

Ulcerative Colitis

Drug: Filgotinib

Drug: Placebo

Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

This study is an open-label study aiming at evaluating the long-term safety and the efficacy profile of ABX464 given once a day (QD) at 25 mg in subj...

Active, not recruiting

Ulcerative Colitis

Drug: ABX464